Phase III trial of COVID-19 vaccine
Latest Information Update: 06 Aug 2021
At a glance
- Drugs COVID-2019 vaccine-Shenzhen Kangtai Biological Products (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 06 Aug 2021 New trial record
- 02 Aug 2021 According to Shenzhen Kangtai Biological Products media release, BIOKANGTAI was approved by the Philippine Food and Drug Administration (PFDA) to launch this phase III clinical trial